People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Resverlogix Corp. | — | Biotechnology | Seed | $1.8M | $81.8M | 2011 |
A. Brad Cann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside A. Brad Cann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eldon R. Smith | 1 | 3 |
| Arthur J. Higgins | 1 | 2 |
| Kenneth J. Zuerblis | 1 | 1 |
| Gregory S. Wagner | 1 | 1 |
| Kenneth O. Lebioda | 1 | 1 |
| Donald J. McCaffrey | 1 | 1 |
| Norman C.W. Wong | 1 | 1 |
| Peter Allan Johann | 1 | 1 |
| Kelly J. McNeill | 1 | 1 |
| F. Allan Gordon | 1 | 1 |
| Jan O. Johansson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.